earnings
confidence high
sentiment positive
materiality 0.80
Amgen Q1 2026 revenue $8.6B (+6% YoY), Non-GAAP EPS $5.15 (+5% YoY)
AMGEN INC
2026-Q1 EPS reported
$3.34
revenue$8,618,000,000
- Total revenue $8.6B (+6% YoY); product sales grew 4% driven by 9% volume growth.
- GAAP EPS $3.34 (+4% YoY); Non-GAAP EPS $5.15 (+5% YoY).
- GAAP operating income $2.7B, margin 32.4% (up 17.4pp); Non-GAAP operating income $3.7B, margin 45.3% (down 0.4pp).
- Free cash flow $1.5B in Q1 2026 vs $1.0B in Q1 2025.
- 16 products achieved double-digit sales growth in Q1 2026.
item 2.02item 9.01